Brain Radiotherapy and Tremelimumab With or Without Trastuzumab in Patients With Breast Cancer Brain Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Brain radiotherapy, tremelimumab-mediated CTLA-4-directed blockade +/- trastuzumab in patients with breast cancer brain metastases
NPJ Breast Cancer 2022 Apr 19;8(1)50, DB Page, K Beal, SN Linch, KJ Spinelli, M Rodine, D Halpenny, S Modi, S Patil, RJ Young, T Kaley, T Merghoub, D Redmond, P Wong, CA Barker, A Diab, L Norton, HL McArthurFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.